Cargando…
Metformin for treatment of clozapine-induced weight gain in adult patients with schizophrenia: a meta-analysis
BACKGROUND: Long-term use of clozapine for individuals with schizophrenia carries a high risk for developing metabolic abnormalities, especially clozapine-induced weight gain. Previous studies suggest that metformin can decrease clozapine-induced weight gain, but the sample sizes of most of these st...
Autores principales: | LIU, Zhengrong, ZHENG, Wei, GAO, Shuai, QIN, Zhisong, LI, Guannan, NING, Yuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shanghai Municipal Bureau of Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858504/ https://www.ncbi.nlm.nih.gov/pubmed/27199524 http://dx.doi.org/10.11919/j.issn.1002-0829.215071 |
Ejemplares similares
-
Clozapine as a first‐ or second‐line treatment in schizophrenia: a systematic review and meta‐analysis
por: Okhuijsen‐Pfeifer, C., et al.
Publicado: (2018) -
Effects of metformin in obesity treatment in different populations: a meta-analysis
por: Pu, Ruiyang, et al.
Publicado: (2020) -
Association of the HTR2C-759C/T polymorphism and antipsychotic-induced weight gain: a meta-analysis
por: Chen, Yan, et al.
Publicado: (2020) -
The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis
por: Xiao, Yao, et al.
Publicado: (2017) -
Maternal Body Mass Index, Diabetes, and Gestational Weight Gain and Risk for Pediatric Cancer in Offspring: A Systematic Review and Meta-Analysis
por: Marley, Andrew R, et al.
Publicado: (2022)